Greywolf Therapeutics has appointed Darlene Deptula-Hicks as Chief Financial Officer. Ms. Deptula-Hicks, an accomplished biotech and healthcare executive, brings over 30 years of corporate finance, capital markets, M&A, accounting and investor relations experience within publicly listed US companies and private healthcare and biotech companies.
Who to call at Grey Wolf Therapeutics, and when
A new leader at Grey Wolf Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day Grey Wolf Therapeutics raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Grey Wolf Therapeutics, from your own LinkedIn network
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Grey Wolf Therapeutics
Location
Milton, Oxfordshire, United Kingdom
About
Grey Wolf Therapeutics is a UK-based drug discovery biotechnology company focused on immuno-oncology and founded by experienced industry professionals Tom McCarthy (Executive Chairman), former President and CEO of Spinifex Pharmaceuticals and Peter Joyce (CEO), formerly of Vertex Pharmaceuticals.
Rather than targeting the immune system, Grey Wolf’s approach is to directly alter the tumour cells, illuminating them for attack and destruction by the immune system. We are targeting a key protein in the antigen presentation pathway to drive modulation of the neoantigen repertoire on tumour cells, thus dramatically increasing tumour visibility and extending the reach of immunotherapy in oncology.
Grey Wolf is working with leading academic and commercial drug discovery partners to deliver a clinical candidate against a strongly validated target. The Grey Wolf team is made up of experts in immuno-oncology, antigen presentation and drug discovery.
For more information, visit the website or email enquiries@gwt.bio.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Grey Wolf Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.